Wi-LAN Inc. (T.WIN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Wi-LAN Inc. (T.WIN)

WILN 1.390

0.0%

Sep 18 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: xanada	9/29/2014 11:10:38 AM
	of 16863

WiLAN Subsidiary Enters License Agreement with Stryker Stryker license represents WiLAN’s first in medical field OTTAWA, Canada – September 29, 2014 – Top intellectual property licensing company, WiLAN (TSX:WIN) (NASD:WILN), today announced that a wholly-owned subsidiary of the company has granted Stryker Corporation (“Stryker”) a license to certain patents related to medical stent technology. WiLAN secured the rights to license the patents through an agreement executed in June 2014. “We are pleased that Stryker has signed this license,” said Jim Skippen, President & CEO. “This license agreement demonstrates our ability to develop and execute licensing programs in new markets such as medical technologies. It also demonstrates our ability to generate timely results for our partners.” The consideration to be paid by Stryker to WiLAN and all other terms of the license agreement are confidential.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next